Global Post-Marketing Pharmacovigilance And Medical Information Market Trends and Future Outlook to 2029
Uncover key drivers, emerging technologies, and competitive movements shaping the post-marketing pharmacovigilance and medical information market from 2025–2034 with trusted insights from The Business Research Company
What CAGR And Valuation Are Anticipated For The Post-Marketing Pharmacovigilance And Medical Information Market?
The post-marketing pharmacovigilance and medical information market has experienced swift expansion recently. Its value is set to increase from $6.16 billion in 2024 to $6.90 billion in 2025, with a compound annual growth rate (CAGR) of 11.9%. Historically, this growth has been driven by factors such as the increasing incorporation of AI into pharmacovigilance procedures, a rising need for outsourced drug safety solutions, the escalating complexity of biopharmaceutical goods, an enhanced emphasis on patient-reported outcomes, and strengthened cooperation between regulatory bodies and the industry.
The post-marketing pharmacovigilance and medical information market size is projected for swift expansion in the coming years, with expectations to reach $10.68 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.6%. This expansion during the forecast period stems from several factors, including enhancements in drug safety analytics tools, the increasing uptake of cloud-based pharmacovigilance solutions, the introduction of more novel therapeutics, a heightened focus on proactive risk management approaches, and expanding pharmacovigilance demands within developing economies. Significant tendencies anticipated during this period encompass improvements in automated adverse event detection, the creation of integrated pharmacovigilance platforms, novel approaches to real-time safety data surveillance, better patient engagement instruments for reporting safety concerns, and the evolution of predictive analytics for evaluating drug risks.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27393&type=smp
What Are The Primary Factors Supporting The Post-Marketing Pharmacovigilance And Medical Information Market Expansion?
The increasing occurrence of adverse drug reactions is projected to drive the expansion of the post-marketing pharmacovigilance and medical information market in the future. Adverse drug reactions are defined as detrimental or unexpected consequences arising from medication use at prescribed dosages for purposes such as prevention, diagnosis, or treatment. The frequency of adverse drug reactions is escalating because the growing elderly population frequently necessitates remedies for various chronic illnesses, resulting in concurrent use of numerous medicines, which elevates the potential for detrimental drug interactions and unforeseen side effects. Post-marketing pharmacovigilance and medical information aid in addressing adverse drug reactions by identifying, monitoring, and disseminating information about possible side effects once a drug is introduced to the market, thereby assisting in upholding its safety and efficacy. As an illustration, in January 2023, Navikenz, a US-based artificial intelligence-focused IT services company, reported that in the US, adverse drug reactions are estimated to cause 200,000 to 400,000 deaths annually, surpassing the combined fatalities from stroke and diabetes, alongside approximately 2.7 million cases each year leading to over 100,000 hospitalizations and more than 15,000 deaths. Consequently, the increasing occurrence of adverse drug reactions is fueling the expansion of the post-marketing pharmacovigilance and medical information market.
Which Segments Define The Structure Of The Post-Marketing Pharmacovigilance And Medical Information Market?
The post-marketing pharmacovigilance and medical information market covered in this report is segmented
1) By Type: Spontaneous Reporting, Intensified Adverse Drug Reaction (ADR) Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, Electronic Health Record (EHR) Mining
2) By Product: Books, Online Media, Journals
3) By End User: Hospitals, Research Organizations, Other End-Users
Subsegments:
1) By Spontaneous Reporting: Consumer Reporting, Healthcare Professional Reporting, Regulatory Authority Reporting, Pharmaceutical Company Reporting, Digital App-Based Reporting
2) By Intensified Adverse Drug Reaction (ADR) Reporting: Hospital-Based Surveillance, Program-Specific Monitoring, Disease-Specific Monitoring, Product-Specific Monitoring, Real-Time Monitoring Systems
3) By Targeted Spontaneous Reporting: Risk Population-Based Reporting, Therapeutic Class-Based Reporting, Adverse Drug Reaction Focused Reporting, Region-Specific Reporting, Healthcare Setting-Specific Reporting
4) By Cohort Event Monitoring: Prospective Cohort Monitoring, Retrospective Cohort Monitoring, Active Follow-Up Monitoring, New Drug User Monitoring, Disease Registry-Linked Monitoring
5) By Electronic Health Record (EHR) Mining: Natural Language Processing-Based Mining, Artificial Intelligence (AI) And Machine Learning Algorithms, Rule-Based Signal Detection, Longitudinal Patient Data Analysis, Integrated Hospital Data Systems
What Strategic Shifts And Innovations Are Influencing The Post-Marketing Pharmacovigilance And Medical Information Market?
Leading entities within the post-marketing pharmacovigilance and medical information market are concentrating on creating sophisticated solutions, such as AI-powered pharmacovigilance workflows, to elevate the precision of adverse event detection and facilitate real-time safety oversight for superior patient results. These AI-powered workflows leverage artificial intelligence to automate drug safety monitoring, allowing for quicker adverse event identification and better adherence to regulations. As an illustration, in January 2024, PubHive Ltd., a UK-based cloud-based software-as-a-service (SaaS) company, launched a unified Summary of Product Characteristics (SmPC) management system designed for life science firms and research organizations. This platform brings together vital drug safety data into a singular, readily available repository, automates literature surveillance and regulatory submissions, improves team cooperation, and optimizes compliance procedures through advanced AI functionalities. Consequently, pharmacovigilance teams can operate more effectively and preemptively, guaranteeing both patient well-being and conformity to regulatory norms.
Who Are The Primary Market Leaders In The Post-Marketing Pharmacovigilance And Medical Information Market?
Major companies operating in the post-marketing pharmacovigilance and medical information market are Cencora Inc., Cardinal Health Inc., Accenture plc, Sanofi S.A., Thermo Fisher Scientific Inc., Capgemini SE, Merck & Co. Inc., Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., HCL Technologies Limited, Laboratory Corporation of America Holdings, ICON plc, WuXi AppTec Co. Ltd., Syneos Health Inc., Genpact Limited, Charles River Laboratories International Inc., Parexel International Corporation, Avalere Health LLC, Quanticate Limited, Inizio Consulting LLC.
Access The Complete Report Here:
What Regional Factors Are Accelerating Growth In The Post-Marketing Pharmacovigilance And Medical Information Market?
North America was the largest region in the post-marketing pharmacovigilance and medical information market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-marketing pharmacovigilance and medical information market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=27393&type=smp
Browse Through More Reports Similar to the Global Post-Marketing Pharmacovigilance And Medical Information Market 2025, By The Business Research Company
Drain Cleaning Equipment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/drain-cleaning-equipment-global-market-report
Prefabricated Buildings Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/prefabricated-buildings-global-market-report
Medical And Surgical Drainage System Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
